BioCrossroads announces 2019 Indiana Life Sciences Summit lineup

2021-04-05T16:47:43-04:00July 10, 2019|

INDIANAPOLIS (July 10, 2019) - BioCrossroads today announced its agenda and launched registration for the 2019 Indiana Life Sciences Summit on Sept. 26 at the Indianapolis Marriott North. The full-day Summit kicks off at 9:00 a.m. with the scientific session, business track, and poster session and ends with the Cook Medical and Eli Lilly and Company Networking Reception. Several announcements about Indiana’s life sciences sector are expected as well, including a new challenge competition and the annual Watanabe Life Sciences Champion of the Year Award. Delivering the same number of sessions and speakers in one full day versus two half days, the speaker line-up includes TED-like talks from life sciences leaders who will discuss artificial intelligence in healthcare and the life sciences. Speakers include Sanji Fernando, vice president at OptumLabs, a collaborative research and innovation center, dedicated to improving patient [...]

BioCrossroads names Patricia Martin President and CEO

2021-04-05T16:47:43-04:00June 26, 2019|

INDIANAPOLIS (June 26, 2019) —BioCrossroads today announced that, after a national search, Patricia (Patty) Martin, a former Eli Lilly and Company executive, has been named president and CEO. A veteran life sciences and community leader, she is BioCrossroads’ third CEO in its 17-year history. At Lilly, Martin was the chief operating officer (COO) of Lilly Diabetes for seven years and also served as Lilly’s Chief Diversity Officer (CDO), Chief Alliance Officer (CAO) and other leadership roles that included strategy, clinical product development, and investor relations. Martin also is involved in Indianapolis non-profit organizations. She is currently a member of the Indiana University Women’s Philanthropy Leadership Council and was the board chair for the 500 Festival in 2016. She succeeds David L. Johnson, who retired from the organization in December to assume his responsibilities as president and CEO of the Central [...]

Increases in workforce, wages, exports and a $79 billion economic impact demonstrates Indiana’s life sciences leadership

2021-04-05T16:47:43-04:00March 5, 2019|

INDIANAPOLIS, Ind., March 5, 2019 -- Indiana’s life sciences industry celebrated an active 2018 with several notable developments and continued its national prominence with a continuation of strong workforce, wages and company statistics. The economic impact of the state’s life sciences industry – comprised of pharmaceutical, medical device and equipment, agbiosciences, research, testing and medical laboratories and biologistics - continues to grow and is now at $79 billion1 (according to data provided to BioCrossroads by the Indiana Business Research Center [IBRC] at the Indiana University Kelley School of Business). Indiana’s number of life sciences companies increased for a second year to 1,7511 from 1,689 last year and an increase of employees, now totaling 56,3231. The average wages for the life sciences sector was $97,6071 per worker, resulting in a life sciences payroll total of $5.5 billion1 for the state. In addition, [...]

Three prominent Indiana life sciences executives join BioCrossroads Board of Directors

2021-04-05T16:47:43-04:00January 31, 2019|

INDIANAPOLIS (January 31, 2019) — BioCrossroads today announces three prominent members of Indiana’s life sciences community have joined its board of directors: Aaron Schacht, executive vice president – Innovation, Regulatory & Business Development, Elanco US Inc.; J.J. Spegele, vice president, global business solutions, Covance Central Laboratory Services; and Dr. Ram Yeleti, executive vice president / chief physician executive, Community Health Network. Schacht leads research & development, regulatory affairs and business development for Elanco Animal Health, following a 25-year career at Lilly in R&D, Strategy and External Innovation roles. Schacht is currently the Chair of the Board of Directors for AgriNovus Indiana, a sister organization to BioCrossroads within the Central Indiana Corporate Partnership. Spegele has held executive leadership roles in operations, laboratory services, general management and information technology for clinical research organizations. He also served as vice president of global business transformation [...]

Go to Top